Gherman, A., Căinap, C., Constantin, A.-M., Cetean, S., & Căinap, S. (2017). Molecular targeted treatment of metastatic colorectal cancer: the cardiovascular adverse effects of Bevacizumab and Cetuximab. Medicine and Pharmacy Reports, 90(4), 377-384. https://doi.org/10.15386/cjmed-745